BIOPHARMA
By
Novartis Announces Agreement with U.S. Government to Support Affordable Access to Medicines
Basel, Switzerland – Novartis, a global leader in innovative medicines, today announced it has reached an agreement with…
BioMarin Announces Agreement to Acquire Amicus Therapeutics in $4.8 Billion Transaction
San Rafael, CA — BioMarin Pharmaceutical Inc. today announced that it has entered into a definitive agreement to…
Bristol Myers Squibb Unveils “Mosaic” AI Content Hub in Mumbai, Advancing Tech-Enabled Patient Engagement
Mumbai, India Bristol Myers Squibb (BMS) today announced the launch of Mosaic, a new artificial intelligence–enabled content hub…
Endpoints Signal Report Finds Nearly Half of Biopharma Professionals Are Heavy AI Users, With Expectations of Major R&D Transformation Ahead
Based on Endpoints Signal Pulse Report | December 2025 A new Signal Pulse Report from Endpoints News reveals…
Will Novartis’ $280M Gene Therapy Plant Transform Denton into a Biopharma Hub?
Denton, TX The Denton City Council has unanimously approved an economic development agreement with Novartis Gene Therapies, paving…
Will Novo Nordisk Pull Ahead of Eli Lilly with FDA Approval of Oral Wegovy?
The U.S. Food and Drug Administration (FDA) has approved the first daily oral version of the obesity drug…
